Summary
Definition
History and exam
Other diagnostic factors
- gastrointestinal symptoms
- urinary urgency or frequency
- symptom duration >3 months
- abdominal distention
- pelvic/abdominal pain or pressure
Risk factors
- genetic mutations associated with hereditary ovarian cancer
- increasing age
- family history of ovarian cancer, breast cancer, colorectal cancer, and/or endometrial cancer
- never used combined oral contraceptives
- nulliparity
- obesity
- hormone therapy
- endometriosis
Diagnostic tests
Treatment algorithm
Contributors
Authors
Sareena Singh, MD
Gynecologic Oncologist
Aultman Medical Group
Northeast Ohio Medical University
Canton
OH
Disclosures
SS declares that she has no competing interests.
Acknowledgements
Dr Sareena Singh would like to gratefully acknowledge Dr Justin C. Chura and Dr Allison E. Axtell, previous contributors to this topic.
Disclosures
JCC and AEA declare that they have no competing interests.
Peer reviewers
Michael P. Hopkins, MD, MEd
Chairman
Obstetrics and Gynecology
Northeast Ohio Universities of Medicine (NEOMED)
Rootstown
OH
Disclosures
MPH declares that he has no competing interests.
Ritu Salani, MD
Gynecologic Oncology Fellow
Johns Hopkins Medical Institutions
Baltimore
MD
Disclosures
RS declares that she has no competing interests.
Susan A. Davidson, MD
Associate Professor
Chief, Gynecologic Oncology
Department of Obstetrics & Gynecology (UCD)
University of Colorado Cancer Center
Aurora
CO
Disclosures
SAD declares that she has no competing interests.
Khadra Galaal, MBChB, MPH, MRCOG
Consultant Gynaecological Oncologist
Northern Gynaecological Oncology Centre
Queen Elizabeth Hospital
Gateshead
UK
Disclosures
KG is co-author of a systematic review of follow-up strategies after primary treatment in ovarian cancer. This is not referenced in this topic.
Jill Tseng, MD
Assistant Clinical Professor of Gynecologic Oncology
University of California, Irvine
Orange
CA
Disclosures
JT declares that she has no competing interests.
Use of this content is subject to our disclaimer